Skip to main content

Angela Vidal Jordana

Institutions of which they are part

Postdoctoral researcher
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Angela Vidal Jordana

Institutions of which they are part

Postdoctoral researcher
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Projects

Esclerosis múltiple: redefiniendo la historia natural

IP: -
Collaborators: Jordi Rio Izquierdo, Georgina Arrambide García, Elena Huerga Núñez, Alex Rovira Cañellas, Angela Vidal Jordana
Funding agency: Instituto de Salud Carlos III
Funding: 105875
Reference: PI14/01439
Duration: 01/01/2015 - 31/12/2017

Intensificació

IP: Intensificació
Collaborators: Angela Vidal Jordana, Miriam Izquierdo Sans
Funding agency: Instituto de Salud Carlos III
Funding: 30000
Reference: INT13/00302
Duration: 01/01/2014 - 31/12/2014

Neurodegeneración y neuroregeneración en esclerosis múltiple: búsqueda de biomarcadores y posibles nuevos tratamientos

IP: Nicolás Miguel Fissolo
Collaborators: Angela Vidal Jordana
Funding agency: Instituto de Salud Carlos III
Funding: 69575
Reference: PI13/00401
Duration: 01/01/2014 - 30/06/2018

Red Española de Esclerosis Múltiple

IP: Red Española de Esclerosis Múltiple
Collaborators: Susana Otero Romero, Carlos Nos Llopis, Red Española de Esclerosis Múltiple, Jaume Sastre Garriga, Jordi Rio Izquierdo, Fco. Javier Aymerich Martínez, Ingrid Galán Cartaña, Rosalia Horno Ocaña, Manuel Comabella Lopez, Carmen Tur Gomez, Cristina Auger Acosta, Herena Eixarch Ahufinger, Montserrat Moreno Sánchez, Alex Rovira Cañellas, Red Española de Esclerosis Múltiple, M Jesus Arevalo Navines, Carmen Espejo Ruiz, Angela Vidal Jordana, Joaquin Castillo Justribo, Mireia Castillo Juarez, Nicolás Miguel Fissolo
Funding agency: Instituto de Salud Carlos III
Funding: 198090
Reference: RD12/0032/0017
Duration: 01/01/2013 - 31/12/2016

Related news

A study conducted at the Catalan Multiple Sclerosis Centre (Cemcat) shows that the lack of a reduction in neurofilament light chain during the first year of treatment is associated with a higher risk of subsequent disease activity.

The project’s 4th annual meeting was recently held as part of the Fortalece–Salud programme of the Carlos III Health Institute.

An international study led by researchers from Vall d’Hebron shows that simple tests that patients can perform themselves help detect changes in disability that may occur even in the absence of disease relapses.

Related professionals

Marina Hortola Bufi

Marina Hortola Bufi

Research technician
Donation and transplantation of organs, tissues and cells
Read more
Miriam Correa Losada

Miriam Correa Losada

Research technician
Stroke research
Read more
Dinara Samarkanova

Dinara Samarkanova

Main researcher
Transfusional Medicine
Read more
Andres Miguez Gonzalez

Andres Miguez Gonzalez

Postdoctoral researcher
Clinical Neuroimmunology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.